You searched for healx • Page 2 of 2 • FRAXA Research Foundation

Less Active Immune System Evident in Fragile X Patients, Study Suggests

February 10, 2020

People with Fragile X syndrome are more likely to develop infections, but are less susceptible to autoimmune disorders than the overall population, a new study found. Taken together, this suggests that the immune system is underactive in this patient population. The study, titled, “The phenotypical implications of immune dysregulation in Fragile X syndrome,” was published in the European Journal of Neurology.

Study Examines Behavioral Traits of Fragile X Patients Without Autism

June 21, 2018

Patients with Fragile X syndrome who don’t meet the cut-off for a diagnosis of autism show a decrease in impulsivity and repetitive questioning over time, when compared with patients who do, a new study shows.

About FRAXA Research Foundation

August 4, 2017

FRAXA Research Foundation’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. FRAXA Research Foundation directly fund research grants and fellowships at top universities around the world. We partner with biomedical and pharmaceutical companies, large and small, to bridge the gap between research discoveries and actual treatments.

FRAXA in the News

October 28, 2022

Read current and past news articles about FRAXA Research Foundation.

Drs. Oostra, Warren, and Nelson discovered the Fragile X gene and its FRAXA mutation in 1991.

Fragile X Syndrome Timeline

April 13, 2023

Discover the evolution of Fragile X research through the work of FRAXA Research Foundation, which is dedicated to finding effective treatments and ultimately a cure for Fragile X syndrome. This interactive timeline showcases milestones, breakthroughs, and key events that have shaped our evolving understanding of Fragile X syndrome.

Forbes, “Clinical Trials Expand For AI-Designed Drug To Treat Fragile X Syndrome”

October 20, 2021

British startup Healx has secured FDA approval for a phase 2a clinical trial of an AI-discovered compound that could help manage the symptoms of the genetic disorder Fragile X syndrome. The start of the trial marks another milestone in the use of artificial intelligence to help find new applications for existing drugs by mining patient records and research databases.